- 4 patents pending producing the best results in the market. Less than $1 a gram production costs per cannabinoid.
- Producing 99% pharmaceutical grade, bioorganic, Non-GMO, 70-90% less than current wholesale prices
- Successfully biosynthesized CBG/CBGA, THCV/THCVA and CBN/CBNA. Sustainably using 90% less resources
- CGA benefits: reduces pain, inflammation; helps treat Inflammatory Bowel disease IDB, Glaucoma, Huntington’s disease
Biosynthesis platform to produce 99% pharmaceutical grade cannabinoids, organic, 100% identical to natural cannabinoids at 70-90less cost using 90% less natural resources
We want to dominate the multi-billion dollar market of rare cannabinoids and fuel the creation of new medical and wellness products leveraging the benefits of these powerful compounds.